SCHEMBL29403700

SCHEMBL29403700

CC1(C)CCC[C@]2(C)c3cc(O)c(O)cc3C(=O)C[C@@H]12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.48
▸ ESR2 Q92731 1/20 0.48
▸ CYP3A4 P08684 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ TSHR P16473 1/20 0.42
▸ SOD1 P00441 1/20 0.42
▸ USP2 O75604 2/20 0.41
▸ GGPS1 O95749 2/20 0.41
▸ FDPS P14324 2/20 0.41
▸ AR P10275 2/20 0.41
▸ HSP90AA1 P07900 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SULT1E1 P49888 1/20 0.39
▸ CYP19A1 P11511 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19770987 0.91 ESR1 (0.46) ESR1ESR2CYP3A4MAPTALDH1A1
SCHEMBL5013007 0.91 ESR1 (0.46) ESR1ESR2CYP3A4MAPTALDH1A1
SCHEMBL5013008 0.91 ESR1 (0.46) ESR1ESR2CYP3A4MAPTALDH1A1
Sugiol SCHEMBL1086916 0.87 SOD1 (0.58) ESR1ESR2CYP3A4MAPTALDH1A1
Sugiol SCHEMBL28605319 0.87 SOD1 (0.58) ESR1ESR2CYP3A4MAPTALDH1A1
Sugiol SCHEMBL17407685 0.87 SOD1 (0.58) ESR1ESR2CYP3A4MAPTALDH1A1
SCHEMBL30697299 0.79 ESR1 (0.46) ESR1ESR2CYP3A4MAPTALDH1A1
SCHEMBL3706021 0.79 CYP3A4 (0.69) ESR1ESR2CYP3A4MAPTALDH1A1
SCHEMBL29637840 0.77 USP2 (0.50) CYP3A4MAPTALDH1A1ALOX15TSHR
SCHEMBL19786216 0.75 ESR1 (0.42) ESR1ESR2CYP3A4MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12186415-B2 Dental enamel compositions with anti-inflammatory agents RAMANA VIVEKANANDA (US) 2025-01-07 — — US claimed
CN-119112850-A Use of Nimbidiol in preparing medicine for preventing and treating inflammation induced angiogenesis 广州医科大学 2024-12-13 — — CN claimed
US-20240197576-A1 DENTAL ENAMEL COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS Ramana, Vivekananda (US) 2024-06-20 — — US claimed
US-11951192-B2 Dental enamel compositions with anti-inflammatory agents RAMANA VIVEKANANDA (US) 2024-04-09 — — US claimed
WO-2023154183-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY (US) 2023-08-17 — — WO claimed
US-20230248618-A1 DENTAL ENAMEL COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS RAMANA VIVEKANANDA (US) 2023-08-10 — — US claimed
US-11654088-B2 Dental enamel compositions with anti-inflammatory agents AMAZON TECHNOLOGIES, INC. 2023-05-23 — — US claimed
US-20220272987-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY H (US) 2022-09-01 — — US claimed
US-20220142873-A1 DENTAL ENAMEL COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS AMAZON TECHNOLOGIES, INC. 2022-05-12 — — US claimed
US-12622433-B2 Bed bug control composition and process of preparing the same COROMANDEL INTERNATIONAL LTD. (IN) 2026-05-12 — — US disclosed
US-12268717-B1 Enhanced microbial therapeutic agents REDDY MALIREDDY S (US) 2025-04-08 — — US disclosed
US-20250089726-A1 BOTANICAL BASED BIO-STIMULANT, BIO-ACARICIDAL COMPOSITIONS KAY BEE BIO ORGANICS PVT LTD (IN) 2025-03-20 — — US disclosed
US-12186415-B2 Dental enamel compositions with anti-inflammatory agents RAMANA VIVEKANANDA (US) 2025-01-07 — — US disclosed
US-12171641-B2 Dental enamel compositions with anti-inflammatory agents for animals RAMANA VIVEKANANDA (US) 2024-12-24 — — US disclosed
US-20220272987-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY H (US) 2022-09-01 — — US disclosed
US-20220233294-A1 DENTAL ENAMEL COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS FOR ANIMALS Ramana, Vivekananda (US) 2022-07-28 — — US disclosed
US-11351019-B2 Dental enamel compositions with anti-inflammatory agents for animals Ramana, Vivekananda 2022-06-07 — — US disclosed
US-20220142873-A1 DENTAL ENAMEL COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS AMAZON TECHNOLOGIES, INC. 2022-05-12 — — US disclosed
US-11266576-B2 Dental enamel compositions with anti-inflammatory agents Ramana, Vivekananda 2022-03-08 — — US disclosed
US-20220061974-A1 DENTAL ENAMEL COMPOSITIONS WITH ANTI-INFLAMMATORY AGENTS FOR ANIMALS Ramana, Vivekananda 2022-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622433-B2 Bed bug control composition and process of preparing the same MERTK, PNMT, HNMT ESR1 1858/4885ESR2 1033/4885CYP3A4 2181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback